Locally Advanced Thyroid Cancer, series of cases, January 2003 – December 2013
Journal Title: Open Access Journal of Endocrinology - Year 2018, Vol 2, Issue 1
Abstract
Objective: The aim of this study is to describe the patients characteristics, histophatologic type, prognosis factor, Shin’s classification and treatment in patients with locally advance thyroid cancer. Methods: Descriptive study. Series of case: 10 patients with diagnosis thyroid cancer locally advance. AMES was used as the prognosis factor system, Shin’s classification to locally advance. The univariatereview was realized with frequency and percentage. Results: 10 patients with locally advance thyroid cancer, 6 male and 4 female, the age range was between 42 and 86 years old, the media was 66.1 years old.
Authors and Affiliations
Francisco Jose Medrano Sanchez
Keywords
Related Articles
- EP ID EP448813
- DOI 10.23880/oaje-16000116
- Views 60
- Downloads 0
An Update on Etiopathogenesis and Management of Type 1 Diabetes Mellitus
The incidence of type 1 diabetes mellitus (T1DM) is increasing at a massive pace globally. It results possibly from a genetic susceptibility and exposure to an environmental trigger. What is important is to use guideline...
Is it Useful to Perform FNAC in Thyroid Gland Diseases?
Background: Neck masses are usually benign, their clinical importance is primarily related to the need to exclude thyroid cancer Thyroid gland cancer accounts for 1% of all cancers and is responsible for 0.5% of death re...
Evaluation of Thyroid Function in a Group of Recently Diagnosed Patients with Thyroid Diseases Followed up at the Endocrinology Outpatient Clinic of the University of Ribeirão Preto (Unaerp) - São Paulo, Brazil
Introduction: The determination of thyroid dysfunction is part of the clinical investigation in different medical specialties. Non-thyroid disorders, certain medications and age may affect the hormonal results. The prese...
Pioglitazone: An Ongoing Misery in the Developing Countries to Which I can’t be Pragmatic!
In 2014, I've published an article warning against the widespread usage of pioglitazone in the developing countries though it has been banned or heavily restricted in all developed countries due to its proved causation w...
HbA1c-Glycated Hemoglobin: Perfect Tool to Curb the Diabetes
Bernard Baruch has very well said this quote as these questions are the basis of science and knowledge. Medical science is not different from it too. In routine day to day practice of medicine we come across with lot man...